165 related articles for article (PubMed ID: 2248738)
21. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
Jin Y; Burns FJ; Garte SJ
Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
[TBL] [Abstract][Full Text] [Related]
22. The amplification of c-erb-B2 in cancer-free surgical margins is a predictor of poor outcome in oral squamous cell carcinoma.
Jelovac DB; Tepavčević Z; Nikolić N; Ilić B; Eljabo N; Popović B; Čarkić J; Konstantinović V; Vukadinović M; Miličić B; Milašin J
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):700-5. PubMed ID: 26708050
[TBL] [Abstract][Full Text] [Related]
23. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
24. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Volling P; Jungehülsing M; Jücker M; Stützer H; Diehl V; Tesch H
Eur J Cancer; 1993; 29A(3):383-9. PubMed ID: 8398339
[TBL] [Abstract][Full Text] [Related]
25. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510
[TBL] [Abstract][Full Text] [Related]
27. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
Machotka SV; Garrett CT; Schwartz AM; Callahan R
Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
[TBL] [Abstract][Full Text] [Related]
28. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
29. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
30. [Oncogenic activity of head and neck tumors].
Basterra J; Armengot M; Martorell M; Barona R; Montalt J
An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
[TBL] [Abstract][Full Text] [Related]
31. [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck].
Rodrigo Tapia JP; García González LA; Martínez Sánchez JA; González Meana MV; García Pedrero JM; Suárez Nieto C
Acta Otorrinolaringol Esp; 2001 Oct; 52(7):539-43. PubMed ID: 11692945
[TBL] [Abstract][Full Text] [Related]
32. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
33. Approximately 580 Kb surrounding the MYC gene is amplified in head and neck squamous cell carcinoma of Indian patients.
Bhattacharya N; Sabbir MG; Roy A; Dam A; Roychoudhury S; Panda CK
Pathol Res Pract; 2005; 201(10):691-7. PubMed ID: 16325511
[TBL] [Abstract][Full Text] [Related]
34. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
35. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
36. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.
Ishitoya J; Toriyama M; Oguchi N; Kitamura K; Ohshima M; Asano K; Yamamoto T
Br J Cancer; 1989 Apr; 59(4):559-62. PubMed ID: 2713242
[TBL] [Abstract][Full Text] [Related]
37. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
38. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
39. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
40. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.
Field JK
J R Soc Med; 1995 Jan; 88(1):35P-39P. PubMed ID: 7884768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
